Generali Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13.7M Buy
20,259
+1,809
+10% +$1.07M 0.24% 91
2026
Q2
$9.25M Buy
18,450
+1,349
+8% +$648K 0.17% 117
2026
Q1
$8.41M Sell
17,101
-3,946
-19% -$2.14M 0.18% 115
2025
Q4
$12.2M Buy
21,047
+4,307
+26% +$2.44M 0.25% 88
2025
Q3
$8.12M Buy
16,740
+258
+2% +$120K 0.17% 114
2025
Q2
$6.68M Sell
16,482
-2,586
-14% -$1.08M 0.15% 143
2025
Q1
$9.49M Buy
19,068
+3,385
+22% +$1.83M 0.23% 97
2024
Q4
$8.16M Buy
+15,683
New +$8.62M 0.21% 105

Other funds holding TMO

Generali Asset Management's TMO Position: Q3 2026 in Review

Generali Asset Management increased its Thermo Fisher Scientific (TMO) stake by 9.8% in Q3 2026, buying an estimated $1.07M and bringing the position to 20,259 shares worth $13.7M. The position accounts for 0.24% of the portfolio, ranked #91.

Generali Asset Management first reported a position in TMO in Q4 2024 and has held it in 8 quarters since. 2,797 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Generali Asset Management held 20,259 shares of Thermo Fisher Scientific worth $13.7M as of Q3 2026.
  • Generali Asset Management bought 1,809 Thermo Fisher Scientific shares in Q3 2026, an estimated $1.07M.
  • Thermo Fisher Scientific made up 0.24% of Generali Asset Management's portfolio in Q3 2026, its #91 holding.
  • Generali Asset Management first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 8 quarters since.
  • 2,797 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Generali Asset Management's 13F filing for Q3 2026, filed 26 Oct 2026.